NURS 497 - Midterm 2 Exam Questions With
Correct Answers
What |would |be |a |result |of |removal |of |the |adrenal |cortex?
A. |Hypernatremia
B. |Hyperglycemia
C. |Hyperkalemia
D. |Decreased |epinephrine
C. |Hyperkalemia
Which |statement |would |be |correct |for |a |client |with |type |2 |diabetes |mellitus |who |is |admitted |
to |the |hospital |with |pneumonia?
a. |The |client |must |receive |insulin |therapy |to |prevent |the |development |of |ketoacidosis.
b. |The |client |has |islet-cell |antibodies |that |have |destroyed |the |ability |of |the |pancreas |to |
produce |insulin.
c. |The |client |has |minimal |or |absent |endogenous |insulin |secretion |and |requires |daily |insulin |
injections.
d. |The |client |may |have |sufficient |endogenous |insulin |to |prevent |ketosis |but |is |at |risk |for |
development |of |hyperosmolar |hyperglycemic |state.
d. |The |client |may |have |sufficient |endogenous |insulin |to |prevent |ketosis |but |is |at |risk |for |
development |of |hyperosmolar |hyperglycemic |state.
Analyze |the |following |diagnostic |findings |for |a |client |with |type |2 |diabetes. |Which |of |the |
following |results |will |need |further |assessment?
a. |A1c |9.0%
b. |FBG |7.2 |mmol/L
c. |BP |126/80
d. |LDL |cholesterol |of |2.1 |mmol/L
a. |A1c |9.0%
Which |of |the |following |are |important |nursing |intervention(s) |when |caring |for |a |client |with |
Cushing's |syndrome? |(Select |all |that |apply)
a. |Restricting |protein |intake
b. |Monitoring |blood |glucose |levels
, c. |Observing |for |signs |of |hypotension
d. |Administering |medication |in |equal |doses
e. |Protecting |the |client |from |exposure |to |infection
b. |Monitoring |blood |glucose |levels
e. |Protecting |the |client |from |exposure |to |infection
A |newly |diagnosed |diabetic |patient |will |exhibit |which |of |the |following |symptoms? |(Select |all |
that |apply.)
A. |Polyphagia
B. |Loss |of |muscle |mass
C. |Polydipsia
D. |Anuria
E. |Weight |loss
A. |Polyphagia
C. |Polydipsia
E. |Weight |loss
Patients |with |uncontrolled |type |2 |diabetes |are |likely |to |experience |which |of |the |following |
complications? |(Select |all |that |apply.)
A. |Peripheral |vascular |disease
B. |Orthostatic |hypotension
C. |Increased |glomerular |filtration |rate |(GFR)
D. |Visual |difficulties
E. |Thickened |capillary |membranes
A. |Peripheral |vascular |disease
B. |Orthostatic |hypotension
D. |Visual |difficulties
E. |Thickened |capillary |membranes
Risk |factors |for |insulin |resistance |include |which |of |the |following? |(Select |all |that |apply.)
A. |Obesity
B. |Medications
C. |Age
D. |Inactivity
E. |Low |fat |diet
A. |Obesity
B. |Medications
Correct Answers
What |would |be |a |result |of |removal |of |the |adrenal |cortex?
A. |Hypernatremia
B. |Hyperglycemia
C. |Hyperkalemia
D. |Decreased |epinephrine
C. |Hyperkalemia
Which |statement |would |be |correct |for |a |client |with |type |2 |diabetes |mellitus |who |is |admitted |
to |the |hospital |with |pneumonia?
a. |The |client |must |receive |insulin |therapy |to |prevent |the |development |of |ketoacidosis.
b. |The |client |has |islet-cell |antibodies |that |have |destroyed |the |ability |of |the |pancreas |to |
produce |insulin.
c. |The |client |has |minimal |or |absent |endogenous |insulin |secretion |and |requires |daily |insulin |
injections.
d. |The |client |may |have |sufficient |endogenous |insulin |to |prevent |ketosis |but |is |at |risk |for |
development |of |hyperosmolar |hyperglycemic |state.
d. |The |client |may |have |sufficient |endogenous |insulin |to |prevent |ketosis |but |is |at |risk |for |
development |of |hyperosmolar |hyperglycemic |state.
Analyze |the |following |diagnostic |findings |for |a |client |with |type |2 |diabetes. |Which |of |the |
following |results |will |need |further |assessment?
a. |A1c |9.0%
b. |FBG |7.2 |mmol/L
c. |BP |126/80
d. |LDL |cholesterol |of |2.1 |mmol/L
a. |A1c |9.0%
Which |of |the |following |are |important |nursing |intervention(s) |when |caring |for |a |client |with |
Cushing's |syndrome? |(Select |all |that |apply)
a. |Restricting |protein |intake
b. |Monitoring |blood |glucose |levels
, c. |Observing |for |signs |of |hypotension
d. |Administering |medication |in |equal |doses
e. |Protecting |the |client |from |exposure |to |infection
b. |Monitoring |blood |glucose |levels
e. |Protecting |the |client |from |exposure |to |infection
A |newly |diagnosed |diabetic |patient |will |exhibit |which |of |the |following |symptoms? |(Select |all |
that |apply.)
A. |Polyphagia
B. |Loss |of |muscle |mass
C. |Polydipsia
D. |Anuria
E. |Weight |loss
A. |Polyphagia
C. |Polydipsia
E. |Weight |loss
Patients |with |uncontrolled |type |2 |diabetes |are |likely |to |experience |which |of |the |following |
complications? |(Select |all |that |apply.)
A. |Peripheral |vascular |disease
B. |Orthostatic |hypotension
C. |Increased |glomerular |filtration |rate |(GFR)
D. |Visual |difficulties
E. |Thickened |capillary |membranes
A. |Peripheral |vascular |disease
B. |Orthostatic |hypotension
D. |Visual |difficulties
E. |Thickened |capillary |membranes
Risk |factors |for |insulin |resistance |include |which |of |the |following? |(Select |all |that |apply.)
A. |Obesity
B. |Medications
C. |Age
D. |Inactivity
E. |Low |fat |diet
A. |Obesity
B. |Medications
